Psychiatry and Neurology, Neurology · Camden, NJ
NPI
1164440483
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
3 Cooper Plz, Suite 215
Camden, NJ, 08103
Phone (856) 342-2445
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,766 services
Medicare patients, 2024
458
Average age 67
Drug cost, 2024
$1.1M
4,546 prescriptions
Company payments, 2025
$21K
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Evren Burakgazi-Dalkilic was code 99214 (office e&m - established), 185 times for 144 patients. In total Evren Burakgazi-Dalkilic billed 1,766 services in 27 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 185 | 144 | $92.45 | $17K |
| 95720 Neurologic | Facility | 137 | 98 | $168.99 | $23K |
| 95819 Neurologic | Facility | 76 | 74 | $43.74 | $3,324 |
| 95718 Neurologic | Facility | 65 | 59 | $107.56 | $6,991 |
| 95816 Neurologic | Facility | 58 | 53 | $45.05 | $2,613 |
| 95816 Neurologic | Office | 37 | 36 | $306.67 | $11K |
| 99204 Office E&M - New | Office | 37 | 37 | $125.29 | $4,636 |
| 95822 Neurologic | Facility | 29 | 26 | $41.79 | $1,212 |
| 99213 Office E&M - Established | Office | 15 | 14 | $58.22 | $873 |
By year: 2022 $86K for 3,467 services; 2023 $83K for 3,792 services; 2024 $85K for 1,766 services.
Medicare prescription drug claims, 2024
In 2024, the drug Evren Burakgazi-Dalkilic prescribed most often to Medicare patients was Levetiracetam, with 791 prescriptions and refills. In total Evren Burakgazi-Dalkilic wrote 4,546 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 791 | 1,415 | 153 | $27K |
| Lacosamide Generic | 488 | 527 | 62 | $70K |
| Oxcarbazepine Generic | 248 | 443 | 43 | $18K |
| Lamotrigine Generic | 219 | 436 | 43 | $3,704 |
| Divalproex Sodium Generic | 197 | 301 | 37 | $17K |
| Zonisamide Generic | 193 | 315 | 33 | $9,861 |
| Topiramate Generic | 161 | 244 | 23 | $2,470 |
| Xcopri Cenobamate | 139 | 146 | 17 | $170K |
| Divalproex Sodium Er Divalproex Sodium | 128 | 191 | 18 | $8,017 |
| Clobazam Generic | 127 | 145 | 12 | $25K |
| Briviact Brivaracetam | 125 | 125 | 12 | $184K |
| Clonazepam Generic | 122 | 122 | 27 | $1,941 |
| Gabapentin Generic | 95 | 190 | 23 | $4,493 |
| Valtoco Diazepam | 87 | 92 | 28 | $156K |
| Carbamazepine Generic | 73 | 94 | Under 11 | $6,300 |
Brand drugs: 571 claims; generic drugs: 3,941 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Evren Burakgazi-Dalkilic $21K ($21K in general payments such as food, travel and fees) from 8 companies. The largest payer was Neurelis, Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.